Cargando…
(13)C MRS and LC–MS Flux Analysis of Tumor Intermediary Metabolism
We present the first validated metabolic network model for analysis of flux through key pathways of tumor intermediary metabolism, including glycolysis, the oxidative and non-oxidative arms of the pentose pyrophosphate shunt, the TCA cycle as well as its anaplerotic pathways, pyruvate–malate shuttli...
Autores principales: | Shestov, Alexander A., Lee, Seung-Cheol, Nath, Kavindra, Guo, Lili, Nelson, David S., Roman, Jeffrey C., Leeper, Dennis B., Wasik, Mariusz A., Blair, Ian A., Glickson, Jerry D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908130/ https://www.ncbi.nlm.nih.gov/pubmed/27379200 http://dx.doi.org/10.3389/fonc.2016.00135 |
Ejemplares similares
-
Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016) -
Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
por: Nath, Kavindra, et al.
Publicado: (2018) -
Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice
por: Nath, Kavindra, et al.
Publicado: (2016) -
pH-dependent structural characteristics of lonidamine: (1)H and (13)C NMR study
por: Gupta, Pradeep Kumar, et al.
Publicado: (2023) -
Development and validation of an LC–MS/MS method for the determination of biogenic amines in wines and beers
por: Nalazek-Rudnicka, Katarzyna, et al.
Publicado: (2017)